AU4788396A - Inhibition of angiogenesis using interleukin-12 - Google Patents

Inhibition of angiogenesis using interleukin-12

Info

Publication number
AU4788396A
AU4788396A AU47883/96A AU4788396A AU4788396A AU 4788396 A AU4788396 A AU 4788396A AU 47883/96 A AU47883/96 A AU 47883/96A AU 4788396 A AU4788396 A AU 4788396A AU 4788396 A AU4788396 A AU 4788396A
Authority
AU
Australia
Prior art keywords
angiogenesis
interleukin
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47883/96A
Other languages
English (en)
Inventor
Moses Judah Folkman
Gary Arthur Truitt
Emile Eugene Voest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Childrens Medical Center Corp
Original Assignee
F Hoffmann La Roche AG
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Childrens Medical Center Corp filed Critical F Hoffmann La Roche AG
Publication of AU4788396A publication Critical patent/AU4788396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU47883/96A 1995-02-16 1996-02-07 Inhibition of angiogenesis using interleukin-12 Abandoned AU4788396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US389382 1989-08-02
US38938295A 1995-02-16 1995-02-16
PCT/EP1996/000507 WO1996025171A1 (fr) 1995-02-16 1996-02-07 Inhibition de l'angiogenese a l'aide de l'interleukine-12

Publications (1)

Publication Number Publication Date
AU4788396A true AU4788396A (en) 1996-09-04

Family

ID=23538033

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47883/96A Abandoned AU4788396A (en) 1995-02-16 1996-02-07 Inhibition of angiogenesis using interleukin-12

Country Status (8)

Country Link
EP (1) EP0809511A1 (fr)
JP (1) JPH11500119A (fr)
AU (1) AU4788396A (fr)
BR (1) BR9607427A (fr)
CA (1) CA2212370A1 (fr)
FI (1) FI973356A (fr)
TR (1) TR199700801T1 (fr)
WO (1) WO1996025171A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022129A1 (fr) * 1996-11-22 1998-05-28 Toray Industries, Inc. Agent therapeutique pour maladies ophtalmiques
US6670337B1 (en) 1998-01-29 2003-12-30 Yeda Reaearch And Development Co., Ltd. Facilitation of wound healing with CM101/GBS toxin
US5981508A (en) 1997-01-29 1999-11-09 Vanderbilt University Facilitation of repair of neural injury with CM101/GBS toxin
US5858991A (en) * 1997-01-29 1999-01-12 Vanderbilt University Facilitation of wound healing with CM101/GBS toxin
US6028060A (en) * 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
WO1998053835A1 (fr) * 1997-05-27 1998-12-03 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Utilisation d'oxydes d'azote ou de promedicament a base de ces oxydes pour la prevention et le traitement therapeutique du cancer
CA2308438A1 (fr) * 1997-11-03 1999-05-14 The Wistar Institute Of Anatomy And Biology Methode et compositions d'inhibition de l'angiogenese et de traitement du cancer
CA2442210C (fr) 2001-03-29 2009-09-08 Schering Corporation Aryloxime-piperazines utiles comme antagonistes de ccr5
WO2004060373A1 (fr) * 2002-12-27 2004-07-22 Santen Pharmaceutical Co., Ltd. Agent therapeutique pour la degenerescence maculaire humide liee a l'age
JP4485520B2 (ja) 2003-03-24 2010-06-23 エフ．ホフマン−ラ ロシュ アーゲー 逆転写酵素阻害剤としてのベンジル−ピリダジノン類
WO2007045573A1 (fr) 2005-10-19 2007-04-26 F. Hoffmann-La Roche Ag Phénylacétamides en tant qu'inhibiteurs de nnrt
AU2007286345B2 (en) 2006-08-16 2012-03-08 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors
AU2007332654B2 (en) 2006-12-13 2013-06-20 F. Hoffmann-La Roche Ag 2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
US20240181010A1 (en) * 2016-07-18 2024-06-06 Neumedicines Inc. Uses of il-12 as a replacement immunotherapeutic

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06506702A (ja) * 1992-01-16 1994-07-28 レプリゲン　コーポレーション 脈管形成性の病気の処置用の新規な方法と組成物
JPH06157344A (ja) * 1992-02-07 1994-06-03 Childrens Medical Center Corp:The 血管新生阻害のための医薬製剤及び血管新生阻害方法

Also Published As

Publication number Publication date
CA2212370A1 (fr) 1996-08-22
FI973356A0 (fi) 1997-08-15
WO1996025171A1 (fr) 1996-08-22
EP0809511A1 (fr) 1997-12-03
TR199700801T1 (xx) 1998-03-21
BR9607427A (pt) 1998-06-23
JPH11500119A (ja) 1999-01-06
FI973356A (fi) 1997-08-15
MX9706188A (es) 1997-11-29

Similar Documents

Publication Publication Date Title
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
AU5893696A (en) Modification of polypeptides
AU5457096A (en) Gene-transfer-mediated angiogenesis therapy
AU7038496A (en) Angiogenesis inhibitor
AU3299195A (en) Inhibition of helicobacter
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
AU5893796A (en) Modification of polypeptides
AU4329396A (en) Use of 3,4-diphenylchromans
GB9512290D0 (en) Uses of polyhexanide
AU7456396A (en) Inhibition of amyloidosis by 9-acridinones
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
AU4788396A (en) Inhibition of angiogenesis using interleukin-12
HUP9602510A1 (en) Preparation of substituted thiazoles
IL116924A0 (en) Preparation of n-aryl- and n-hetarylhydroxylamines
AU5381696A (en) Synthesis of bis-indolylmaleimides
AU5157796A (en) Whipstock
AU2217797A (en) Synthesis of indolylmaleimides
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU4157097A (en) Synthesis of bisindolylmalimides
AU4396396A (en) Baby-bathing aid
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU3948395A (en) Synthesis of 6-azaandrostenones
AU5126298A (en) Inhibition of crib-biting
AU7416896A (en) Wall element
AU2993095A (en) Cyclone